Israel Englander’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Israel Englander’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,866	Closed	-$9.33K	–	6681
2023 Q3	$9.33K	Sell	1,866 -518	-22%	-$3.21K	﹤0.01%	5772
2023 Q2	$16.6K	Sell	2,384 -7,077	-75%	-$61K	﹤0.01%	5663
2023 Q1	$90K	Sell	9,461 -10,765	-53%	-$113K	﹤0.01%	5459
2022 Q4	$123K	Buy	20,226 +13,769	+213%	+$172K	﹤0.01%	5508
2022 Q3	$90K	Sell	6,457 -795	-11%	-$23.3K	﹤0.01%	6005
2022 Q2	$292K	Buy	+7,252	New	+$449K	﹤0.01%	5404
2022 Q1	–	Sell	-2,467	Closed	-$284K	–	7686
2021 Q4	$284K	Sell	2,467 -388	-14%	-$93.2K	﹤0.01%	5596
2021 Q3	$1.08M	Buy	2,855 +2,147	+303%	+$720K	﹤0.01%	4589
2021 Q2	$289K	Sell	708 -3,508	-83%	-$1.62M	﹤0.01%	5757
2021 Q1	$2.01M	Buy	+4,216	New	+$2.29M	﹤0.01%	3529

Other funds holding NEXI

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Israel Englander's NEXI Position: Q4 2023 in Review

Israel Englander sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2023, closing a stake of 1,866 shares — an estimated $9.33K sold.

Israel Englander first reported a position in NEXI in Q1 2021 and held it in 10 quarters. The position peaked at $2.01M in Q1 2021. 11 funds tracked by Wall St. Rank hold NEXI as of Q4 2023.

Israel Englander reported no remaining NexImmune, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Israel Englander sold 1,866 NexImmune, Inc. Common Stock shares in Q4 2023, an estimated $9.33K.
Israel Englander first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
Israel Englander's NexImmune, Inc. Common Stock position peaked at $2.01M in Q1 2021.
11 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2023.

Based on Millennium Management's 13F filing for Q4 2023, filed 14 Feb 2024.